You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Ottawa, Montreal (Indacaterol maleate, Placebo)

Completed
  • Asthma
  • Indacaterol maleate
  • Placebo
  • Ottawa, Ontario, Canada
  • +1 more
Dec 16, 2020

Asthma Trial in Worldwide (FS MDPI, Fp MDPI, Placebo MDPI)

Completed
Has Results
  • Asthma
  • FS MDPI
  • +4 more
  • Birmingham, Alabama
  • +139 more
Nov 11, 2021

Asthma Trial in Worldwide (FS MDPI, Fp MDPI, Placebo MDPI)

Completed
Has Results
  • Asthma
  • FS MDPI
  • +3 more
  • Birmingham, Alabama
  • +153 more
Nov 5, 2021

Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)

Recruiting
  • Bronchial Asthma
  • Single Inhalation technique
  • Tidal inhalation technique
  • Chandigarh, India
  • +1 more
Jun 23, 2022

Asthma, Cough Variant Asthma Trial in Warsaw (Budesonid or budesonide/fomoterol administered by DPI, Budesonid or

Recruiting
  • Asthma
  • Cough Variant Asthma
  • Budesonid or budesonide/fomoterol administered by DPI
  • Budesonid or budesonide/fomoterol administered by MDI
  • Warsaw, Poland
    Department of Internal Medicine, Pneumonology and Allergology, M
Jul 7, 2021

Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg

Completed
  • Refractory Chronic Cough
  • 3 mg NOC-100 (via nebulizer)
  • +5 more
  • Phoenix, Arizona
  • +2 more
Nov 16, 2022

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

Asthma Trial in United States (Albuterol Spiromax®, ProAir® HFA, Placebo Inhaler)

Completed
Has Results
  • Asthma
  • Albuterol Spiromax®
  • +2 more
  • Huntington Beach, California
  • +12 more
Nov 5, 2021

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

Persistent Asthma Trial in United States (Fp MDPI, FS MDPI, FLOVENT HFA)

Completed
Has Results
  • Persistent Asthma
  • Fp MDPI
  • +4 more
  • Birmingham, Alabama
  • +100 more
Nov 6, 2021

Asthma Trial in Worldwide (AZD4604, Placebo)

Not yet recruiting
  • Asthma
  • Stockton, California
  • +24 more
Aug 25, 2023

Asthma Trial in Worldwide (Fluticasone Propionate, Fluticasone Propionate/Salmeterol, Placebo MDPI)

Completed
Has Results
  • Asthma
  • Fluticasone Propionate
  • +2 more
  • Birmingham, Alabama
  • +117 more
Nov 5, 2021

Asthma Trial in Thailand, United States (Albuterol MDPI, Placebo, ProAir HFA inhaler)

Completed
Has Results
  • Asthma
  • Albuterol MDPI
  • +2 more
  • Birmingham, Alabama
  • +51 more
Nov 5, 2021

Asthma Trial in United States (Albuterol dry powder inhaler, Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler))

Completed
  • Asthma
  • Albuterol dry powder inhaler
  • Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
  • Los Angeles, California
  • +8 more
Jan 18, 2022

Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
    • São Paulo, Brazil
      Boehringer Ingelheim Brasil
    Sep 22, 2023

    Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

    Not yet recruiting
    • Asthma
    • (no location specified)
    Mar 18, 2023

    Healthy Volunteers Trial in Baltimore, Springfield (ASA, non-enteric-coated chewable aspirin)

    Recruiting
    • Healthy Volunteers
    • ASA
    • non-enteric-coated chewable aspirin
    • Baltimore, Maryland
    • +1 more
    Nov 21, 2022

    Asthma, Airway Inflammation Trial (mometasone furoate/formoterol 100/10 mcg, mometasone furoate/formoterol 200/10 mcg,

    Completed
    Has Results
    • Asthma
    • Airway Inflammation
    • mometasone furoate/formoterol 100/10 mcg
    • +5 more
    • (no location specified)
    Feb 7, 2022

    Obstructive Pulmonary Function, Restrictive Pulmonary Function Trial in Winter Park, Baltimore, Berlin (single dose (100 mg) of

    Not yet recruiting
    • Obstructive Pulmonary Function
    • Restrictive Pulmonary Function
    • single dose (100 mg) of ASA
    • single dose (162 mg) of non-enteric-coated chewable aspirin tablets
    • Winter Park, Florida
    • +2 more
    Nov 21, 2022

    Asthma Trial (Educational intervention)

    Not yet recruiting
    • Asthma
    • Educational intervention
    • (no location specified)
    Oct 18, 2023

    Asthma Trial in Mineola (In-Check Dial, Inhaler Device)

    Completed
    • Asthma
    • In-Check Dial
    • Inhaler Device
    • Mineola, New York
      Winthrop University Hospital
    Feb 27, 2023

    Asthma Trial (mometasone furoate dry powder inhaler, Budesonide DPI)

    Completed
    Has Results
    • Asthma
    • mometasone furoate dry powder inhaler
    • Budesonide DPI
    • (no location specified)
    Feb 7, 2022

    Bioequivalence, Asthma Trial in Larissa (Test, Reference)

    Active, not recruiting
    • Bioequivalence
    • Asthma
    • Larissa, Thessaly, Greece
      BECRO Clinical Facility
    Oct 19, 2021